Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

Clinical trial NCT05352178 · RECRUITING

Trial details

NCT number: NCT05352178
Sponsor: Universitaire Ziekenhuizen KU Leuven
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer Prostate Cancer Recurrent Prostate Cancer Metastatic Metastatic Cancer Oligometastatic Disease Oligometastasis Hormone Sensitive Prostate Cancer

Start date: 2022-04-20
Primary completion: 2027-04-25
Enrollment: 873

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.